We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$112M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow %
97.19%
Top 10 Hldgs %
17.56%
Holding
540
New
540
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.69M
2
UL icon
Unilever
UL
+$2.44M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.92M
4
AAPL icon
Apple
AAPL
+$1.87M
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$1.85M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 20.32%
2 Healthcare 10.43%
3 Financials 10.4%
4 Energy 10.29%
5 Industrials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
276
Novartis
NVS
$297B
$13K 0.01%
+185
New +$12.9K
TWO
277
Two Harbors Investment
TWO
$1.27B
$13K 0.01%
+188
New +$14.1K
PXD
278
DELISTED
Pioneer Natural Resource Co.
PXD
$13K 0.01%
+75
New +$14.4K
EWY icon
279
iShares MSCI South Korea ETF
EWY
$21.9B
$12K 0.01%
+200
New +$12.7K
JWN
280
DELISTED
Nordstrom
JWN
$12K 0.01%
+200
New +$12K
PNC icon
281
PNC Financial Services
PNC
$99.7B
$12K 0.01%
+166
New +$12.4K
TSLA icon
282
Tesla
TSLA
$1.23T
$12K 0.01%
+1,200
New +$12.3K
STJ
283
DELISTED
St Jude Medical
STJ
$12K 0.01%
+200
New +$11.6K
CMCSA icon
284
Comcast
CMCSA
$85B
$11K 0.01%
+454
New +$10.9K
ED icon
285
Consolidated Edison
ED
$40.1B
$11K 0.01%
+200
New +$11.3K
GDL
286
GDL Fund
GDL
$91.6M
$11K 0.01%
+1,000
New +$11.2K
MS icon
287
Morgan Stanley
MS
$331B
$11K 0.01%
+375
New +$11.1K
NOC icon
288
Northrop Grumman
NOC
$77.1B
$11K 0.01%
+100
New +$10.7K
PSA icon
289
Public Storage
PSA
$60.5B
$11K 0.01%
+75
New +$12K
XLK icon
290
State Street Technology Select Sector SPDR ETF
XLK
$115B
$11K 0.01%
+630
New +$10.7K
CPAY icon
291
Corpay
CPAY
$25B
$11K 0.01%
+100
New +$11.5K
ETFC
292
DELISTED
E*Trade Financial Corporation
ETFC
$11K 0.01%
+800
New +$14.2K
GNMX
293
DELISTED
Aevi Genomic Medicine Inc
GNMX
$11K 0.01%
+2,000
New +$13.1K
AGU
294
DELISTED
Agrium
AGU
$11K 0.01%
+121
New +$10.7K
DFT
295
DELISTED
DuPont Fabros Technology Inc.
DFT
$11K 0.01%
+447
New +$10.9K
KOG
296
DELISTED
KODIAK OIL & GAS CORP
KOG
$11K 0.01%
+1,000
New +$12K
CAG icon
297
Conagra Brands
CAG
$6.94B
$10K 0.01%
+393
New +$9.82K
TM icon
298
Toyota
TM
$224B
$10K 0.01%
+86
New +$10.8K
VEA icon
299
Vanguard FTSE Developed Markets ETF
VEA
$229B
$10K 0.01%
+250
New +$10.1K
ARIA
300
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$10K 0.01%
+1,500
New +$8.1K
10 11
12
13 14

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Kavar Capital Partners Group's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Kavar Capital Partners Group, which disclosed 540 positions worth $112M. Its ten largest holdings account for 18% of the portfolio.

Its largest position is Procter & Gamble: 33,008 shares worth $2.69M.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, followed by Healthcare and Financials.

  • Kavar Capital Partners Group's largest Q4 2013 buy was Procter & Gamble: 33,008 shares worth $2.69M.
  • Kavar Capital Partners Group's ten largest holdings make up 18% of its $112M portfolio in Q4 2013.
  • Kavar Capital Partners Group disclosed 540 positions in Q4 2013, its first 13F filing on record.

Based on Kavar Capital Partners Group's 13F filing for Q4 2013, filed 7 Jan 2019.